X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (139) 139
male (101) 101
index medicus (99) 99
oncology (94) 94
middle aged (59) 59
aged (51) 51
cancer (46) 46
carcinoma, renal cell - drug therapy (44) 44
kidney neoplasms - drug therapy (43) 43
female (41) 41
sunitinib (40) 40
prostate cancer (37) 37
kidney neoplasms - pathology (32) 32
antineoplastic agents - therapeutic use (30) 30
prostatic neoplasms - drug therapy (30) 30
treatment outcome (30) 30
adult (29) 29
carcinoma, renal cell (28) 28
care and treatment (27) 27
endothelial growth-factor (27) 27
metastasis (27) 27
survival (27) 27
interferon-alpha (26) 26
aged, 80 and over (25) 25
urology & nephrology (25) 25
neoplasm metastasis (24) 24
renal cell carcinoma (24) 24
article (23) 23
carcinoma, renal cell - pathology (23) 23
hematology, oncology and palliative medicine (23) 23
sorafenib (23) 23
drug therapy (22) 22
clinical trials (21) 21
vascular endothelial growth factor (21) 21
prostatic neoplasms - pathology (20) 20
urology (20) 20
angiogenesis inhibitors - therapeutic use (19) 19
indoles - therapeutic use (19) 19
neoplasm staging (19) 19
phase-ii trial (19) 19
protein kinase inhibitors - therapeutic use (19) 19
pyrroles - therapeutic use (19) 19
research (19) 19
therapy (19) 19
tumors (19) 19
angiogenesis (18) 18
bevacizumab (18) 18
disease-free survival (18) 18
risk factors (18) 18
analysis (17) 17
animals (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
carcinoma, renal cell - mortality (16) 16
double-blind (16) 16
everolimus (16) 16
kidney neoplasms - mortality (16) 16
prognosis (16) 16
tyrosine kinase inhibitor (16) 16
carcinoma, renal cell - secondary (15) 15
chemotherapy (15) 15
docetaxel (14) 14
indoles - adverse effects (14) 14
pyrroles - adverse effects (14) 14
clinical trials as topic (13) 13
efficacy (13) 13
medicine & public health (13) 13
patient outcomes (13) 13
targeted therapy (13) 13
abridged index medicus (12) 12
antineoplastic agents (12) 12
antineoplastic agents - adverse effects (12) 12
indoles - administration & dosage (12) 12
phase-ii (12) 12
pyrroles - administration & dosage (12) 12
retrospective studies (12) 12
trial (12) 12
antimitotic agents (11) 11
bone neoplasms - secondary (11) 11
carcinoma (11) 11
disease progression (11) 11
drug resistance, neoplasm (11) 11
expression (11) 11
hypertension (11) 11
molecular targeted therapy (11) 11
vegf (11) 11
antitumor-activity (10) 10
development and progression (10) 10
health aspects (10) 10
imidazoles - therapeutic use (10) 10
prostatic neoplasms - therapy (10) 10
receptors, vascular endothelial growth factor - antagonists & inhibitors (10) 10
urologic and male genital diseases (10) 10
antineoplastic agents - administration & dosage (9) 9
biomarkers, tumor - blood (9) 9
cancer therapies (9) 9
carcinoma, renal cell - metabolism (9) 9
combination (9) 9
dosage and administration (9) 9
drug administration schedule (9) 9
growth (9) 9
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Robarts - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Humber River Regional Hospital - Church Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Baycrest Hospital - Course Reserves (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Stacks (1) 1
Criminology - Stacks (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Course Reserves (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Law (Bora Laskin) - Stacks (1) 1
OISE - Reference (1) 1
Online Resources - Online (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
St Josephs Health Centre - Reference (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
Women's College Hospital - Pharmacy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Oncologist, ISSN 1083-7159, 06/2019, Volume 24, Issue 6, pp. 725 - 727
Combination therapies involving antiangiogenic agents plus immune checkpoint inhibitors have recently demonstrated clinical efficacy in advanced renal cell... 
EVEROLIMUS | AXITINIB | ONCOLOGY | BEVACIZUMAB | SUNITINIB | COMBINATION | NIVOLUMAB | CANCER | Commentaries
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 552 - 562
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9807, pp. 1931 - 1939
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2007, Volume 356, Issue 2, pp. 115 - 124
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 22, pp. 3584 - 3590
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 01/2010, Volume 7, Issue 1, pp. 7 - 8
Motzer and colleagues present updated results from a multicenter, phase III trial of sunitinib versus interferon-alpha as first-line treatment for patients... 
PHASE-III TRIAL | DOUBLE-BLIND | EFFICACY | ONCOLOGY | SAFETY | RENAL-CELL CARCINOMA
Journal Article
Journal Article
PLOS ONE, ISSN 1932-6203, 08/2019, Volume 14, Issue 8, p. e0215761
Journal Article
Journal Article